Pfizer
Pfizer
Community score
moreFounded in 1849, the corporation has its headquarters in New York City, New York, United States, and is recognized for its diverse portfolio in the biopharmaceutical sector. Among the critical areas of focus are internal medicine, oncology, vaccine development, inflammation and immunology, rare diseases, and hospital products, which constitute vital components of their operations. Within the biopharmaceutical segment, vaccines are a significant area of emphasis. A prominent example is the COVID-19 vaccine, developed in collaboration with BioNTech. The oncology division has also established a robust presence in the cancer treatment market with a suite of therapy options for various types of cancer. Historically, the consumer healthcare segment was part of the business until it transitioned into a joint venture with GlaxoSmithKline, forming GSK Consumer Healthcare. However, this part of the company has since been spun off into an independent entity known as Haleon. Prominent brands from this corporation include the Prevnar family, known for pneumococcal vaccines; Ibrance (palbociclib), a cancer treatment; Eliquis (apixaban), an anticoagulant; Vyndaqel/Vyndamax (tafamidis), for treating the rare disease ATTR-CM; Xeljanz (tofacitinib), aimed at certain autoimmune conditions; and the smoking cessation aid Chantix (varenicline), although Chantix was sold to Haleon. Additionally, the BNT162b2 vaccine, branded as Comirnaty, constitutes a landmark development in the fight against the global COVID-19 pandemic. Globally, this corporation's products and services are available in over 125 countries, with significant markets in the United States, China, Japan, Germany, France, Italy, Spain, the United Kingdom, Canada, and Brazil. These countries are indicative of the corporation's extensive reach and importance on a global scale. (Powered by AI)
According to the ILO, an organization needs to achieve a gender balance of 40:60% representation of either gender1;p12. Gender inequality reduces the socio-economic status of women, causes psychological and physical stress, and affects their menta...
GHGs trap the Sun's heat and cause a rise in temperature, sea level, extreme weather conditions, and climate change1. Industries need to develop carbon-free systems to meet the Paris Agreement's goal of keeping the atmospheric temperature rise wel...
Globally, around 50% of the population doesn't have access to essential healthcare services1. In the US, in 2021, an estimated 46 million (Mn) people reported that they wouldn't be able to pay for proper healthcare, while 12% of Americans reported...
The success of significant novel solutions, products, and services depends on research and development (R&D), which provides insights to improve current processes in various industries1. The development of novel & enhanced drugs and vaccines depen...
Nearly 2 billion (Bn) people across the globe don’t have access to basic medicines1. Lack of medicines is a major barrier to good health. Providing basic medicines to underserved countries can reduce mortality and prevent deaths from diseases th...